DeepIntent Survey Reveals That Pharmaceutical Advertising Motivates Patients to Research Treatment and Medication Options

DeepIntent surveyed 1,244 U.S. patients in August 2021 about their attitudes toward pharmaceutical ads and whether they find them relevant.

In this article, Pharmaceutical Executive Magazine shares key takeaways from the survey revealing how advertising motivates patients to research their treatment and medication options. DeepIntent’s CEO Chris Paquette also shares the opportunities healthcare marketers can act on as a result of this research.

Read more here.

More Insights

Improving Patient Outcomes with Machine Learning

Artificial intelligence and machine learning technology are revolutionizing the healthcare industry right before our very eyes. In this article for AiThority.com, CEO Chris Paquette…

Read More
Is that drug ad for me? People pay more attention to pharma DTC for familiar conditions, study finds

When pharma ads are relevant, they drive patient action. In this article, Endpoints News highlights the findings from DeepIntent’s research study on patient attitudes…

Read More
Shrinking Linear Television Underscores Shift to Emerging Channels

As linear TV viewership continues its decline, pharma marketers will need to adjust their strategies to reach healthcare audiences on all screens. In this video…

Read More
Subscribe to Our NewsletterJoin our mailing list to get the latest product updates, actionable insights, and resources for healthcare marketers and publishers.

By clicking ‘Submit’ you agree to our Terms and Privacy Policy